Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
544 | American Pharmaceutical Review | journal | 0.103 Q4 | 26 | 0 | 29 | 0 | 4 | 27 | 0.00 | 0.00 | 0.00 | |
543 | Circular Farmaceutica | journal | 0.103 Q4 | 3 | 0 | 11 | 0 | 0 | 10 | 0.00 | 0.00 | 0.00 | |
542 | Current Protocols in Pharmacology | journal | 0.670 Q2 | 39 | 0 | 11 | 0 | 30 | 11 | 0.00 | 0.00 | 0.00 | |
541 | Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.] | journal | 0.115 Q4 | 31 | 0 | 10 | 0 | 4 | 10 | 0.00 | 0.00 | 0.00 | |
540 | Drug Discovery Today: Disease Models | journal | 0.665 Q2 | 33 | 0 | 23 | 0 | 64 | 20 | 0.00 | 0.00 | 0.00 | |
539 | EPC - European Pharmaceutical Contractor | journal | 3 | 7 | 0 | 20 | 0 | 0 | 0.00 | 2.86 | 28.57 | ||
538 | Epitheorese Klinikes Farmakologias kai Farmakokinetikes | journal | 0.138 Q4 | 5 | 17 | 46 | 385 | 3 | 45 | 0.00 | 22.65 | 71.43 | |
537 | Frontiers in Clinical Drug Research - Anti Allergy Agents | book series | 0.111 Q4 | 1 | 0 | 12 | 0 | 1 | 3 | 0.00 | 0.00 | 0.00 | |
536 | Frontiers in Clinical Drug Research - Anti Infectives | book series | 0.104 Q4 | 2 | 0 | 20 | 0 | 1 | 9 | 0.00 | 0.00 | 0.00 | |
535 | GMP Review | trade journal | 0.101 Q4 | 2 | 4 | 39 | 28 | 0 | 24 | 0.00 | 7.00 | 0.00 | |
534 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.133 Q4 | 50 | 4 | 1 | 194 | 0 | 1 | 0.00 | 48.50 | 0.00 | |
533 | Industrial Pharmacy | trade journal | 0.108 Q4 | 5 | 0 | 5 | 0 | 0 | 4 | 0.00 | 0.00 | 0.00 | |
532 | Interdisciplinary Toxicology | journal | 1.583 Q1 | 38 | 0 | 6 | 0 | 74 | 6 | 0.00 | 0.00 | 0.00 | |
531 | Japanese Pharmacology and Therapeutics | journal | 0.120 Q4 | 18 | 2 | 46 | 1 | 7 | 44 | 0.00 | 0.50 | 0.00 | |
530 | Journal of Experimental Therapeutics and Oncology | journal | 0.108 Q4 | 40 | 0 | 5 | 0 | 0 | 4 | 0.00 | 0.00 | 0.00 | |
529 | Manufacturing Chemist | trade journal | 0.100 Q4 | 6 | 0 | 164 | 0 | 0 | 162 | 0.00 | 0.00 | 0.00 | |
528 | Molecular and Cellular Pharmacology | journal | 0.133 Q4 | 28 | 3 | 5 | 15 | 0 | 1 | 0.00 | 5.00 | 0.00 | |
527 | National Toxicology Program technical report series | journal | 0.111 Q4 | 22 | 2 | 5 | 185 | 1 | 5 | 0.00 | 92.50 | 0.00 | |
526 | NTP Developmental and Reproductive Toxicity Technical Report Series | book series | 0.111 Q4 | 1 | 0 | 11 | 0 | 0 | 3 | 0.00 | 0.00 | 0.00 | |
525 | NTP Immunotoxicity Technical Report Series | book series | 0.133 Q4 | 0 | 0 | 3 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
524 | NTP Research Report Series | book series | 0.117 Q4 | 3 | 1 | 4 | 21 | 1 | 4 | 0.00 | 21.00 | 0.00 | |
523 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 0.111 Q4 | 9 | 2 | 3 | 348 | 0 | 3 | 0.00 | 174.00 | 63.24 | |
522 | Oral Therapeutics and Pharmacology | journal | 0.102 Q4 | 6 | 5 | 16 | 98 | 1 | 16 | 0.00 | 19.60 | 20.00 | |
521 | Pharmaceutical Manufacturing and Packing Sourcer | trade journal | 0.102 Q4 | 3 | 0 | 14 | 0 | 0 | 14 | 0.00 | 0.00 | 0.00 | |
520 | Pharmaceutical Outsourcing | journal | 0.103 Q4 | 7 | 0 | 15 | 0 | 0 | 12 | 0.00 | 0.00 | 0.00 | |
519 | Pharmaceutical Technology in Hospital Pharmacy | journal | 0.211 Q4 | 1 | 0 | 2 | 0 | 4 | 2 | 0.00 | 0.00 | 0.00 | |
518 | Pharmaceutisch Weekblad | journal | 0.100 Q4 | 9 | 516 | 1117 | 8 | 2 | 687 | 0.00 | 0.02 | 59.46 | |
517 | Pharmacy Times | trade journal | 0.100 Q4 | 8 | 62 | 341 | 387 | 1 | 233 | 0.00 | 6.24 | 63.16 | |
516 | Pharmazeutische Zeitung | journal | 0.100 Q4 | 7 | 742 | 2583 | 307 | 1 | 1051 | 0.00 | 0.41 | 57.30 | |
515 | PZ Prisma | journal | 0.100 Q4 | 5 | 21 | 103 | 311 | 0 | 92 | 0.00 | 14.81 | 34.48 | |
514 | Arzneimitteltherapie | journal | 0.101 Q4 | 6 | 153 | 432 | 647 | 5 | 257 | 0.01 | 4.23 | 53.70 | |
513 | Drug Topics | journal | 0.104 Q4 | 8 | 104 | 412 | 180 | 2 | 71 | 0.01 | 1.73 | 63.64 | |
512 | Drug Development and Delivery | trade journal | 0.104 Q4 | 12 | 79 | 198 | 606 | 5 | 89 | 0.02 | 7.67 | 32.14 | |
511 | Drug Delivery System | journal | 0.102 Q4 | 9 | 42 | 177 | 827 | 6 | 136 | 0.03 | 19.69 | 20.00 | |
510 | Pharmaceutical Technology Europe | journal | 0.111 Q4 | 19 | 127 | 287 | 630 | 8 | 227 | 0.03 | 4.96 | 53.23 | |
509 | Regulatory Rapporteur | trade journal | 0.101 Q4 | 7 | 69 | 167 | 715 | 3 | 96 | 0.03 | 10.36 | 61.19 | |
508 | Pharmaceutical Journal | journal | 0.115 Q4 | 28 | 71 | 1739 | 570 | 90 | 1643 | 0.05 | 8.03 | 57.81 | |
507 | BioPharm International | trade journal | 0.106 Q4 | 32 | 112 | 274 | 423 | 17 | 89 | 0.06 | 3.78 | 35.85 | |
506 | Geneesmiddelenbulletin | journal | 0.158 Q4 | 7 | 17 | 68 | 307 | 5 | 68 | 0.07 | 18.06 | 23.08 | |
505 | Journal of Angiotherapy | journal | 0.106 Q4 | 2 | 40 | 57 | 1623 | 4 | 57 | 0.07 | 40.58 | 37.37 | |
504 | Japanese Journal of Chemotherapy | journal | 0.108 Q4 | 13 | 0 | 62 | 0 | 7 | 62 | 0.08 | 0.00 | 0.00 | |
503 | Drugs of the Future | journal | 0.150 Q4 | 46 | 7 | 262 | 208 | 27 | 261 | 0.09 | 29.71 | 34.62 | |
502 | Japanese Journal of Clinical Pharmacology and Therapeutics | journal | 0.119 Q4 | 8 | 39 | 110 | 499 | 11 | 103 | 0.09 | 12.79 | 40.98 | |
501 | Klinicka Farmakologie a Farmacie | journal | 0.108 Q4 | 5 | 19 | 91 | 470 | 11 | 82 | 0.09 | 24.74 | 52.94 | |
500 | Pharmaceutical Technology | journal | 0.138 Q4 | 42 | 116 | 377 | 509 | 31 | 159 | 0.09 | 4.39 | 51.16 | |
499 | Sangyo eiseigaku zasshi = Journal of occupational health | journal | 0.136 Q4 | 15 | 29 | 57 | 0 | 7 | 57 | 0.10 | 0.00 | 29.37 | |
498 | Actualites Pharmaceutiques | journal | 0.133 Q4 | 6 | 194 | 545 | 1670 | 51 | 434 | 0.11 | 8.61 | 51.38 | |
497 | Pharmakeftiki | journal | 0.125 Q4 | 6 | 14 | 47 | 500 | 6 | 45 | 0.11 | 35.71 | 40.38 | |
496 | ONdrugDelivery | trade journal | 0.131 Q4 | 7 | 145 | 251 | 700 | 29 | 173 | 0.12 | 4.83 | 24.31 | |
495 | Journal of Caffeine and Adenosine Research | journal | 0.112 Q4 | 1 | 0 | 8 | 0 | 1 | 5 | 0.13 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®